Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 45
Filter
Add more filters










Publication year range
1.
Mol Genet Metab Rep ; 31: 100853, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35782612

ABSTRACT

Background: Little is known about pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency (PDE-ALDH7A1) in adulthood, as the genetic basis of the disorder has only been elucidated 15 years ago. This creates a knowledge gap for physicians, pediatric patients and their parents, which was aimed to address in this study using clinical data as well as patient-reported outcome measures (PROMs) for the patient's perspective. Methods: Dutch, genetically confirmed PDE-ALDH7A1 patients ≥18 years were eligible for inclusion. Clinical data were collected as well as PROMs (PROMIS item banks Anxiety, Depression, Anger, Physical Functioning, Cognitive Functioning, Cognitive Abilities, Ability to Participate and Satisfaction with Social Roles). Results: Ten out of 11 patients agreed to participate (91% response rate). Seizure control at last follow up (median age 25.2 years, range 17.8-29.8 years) was achieved with pyridoxine monotherapy in 70%, 20% with adjunct common-anti epileptic drugs and 10% did not obtain complete seizure control. Neurologic symptoms were present in all but one patient (90%) and included tremors, noted in 40%. Neuro-imaging abnormalities were present in 80%. Intellectual disability was present in 70%. One patient (10%) attended university, three maintained a job without assistance, five maintained a job with assistance or attended social daycare, and one patient never followed regular education. The cohort scored significantly lower on the PROMIS Cognitive Functioning compared to the general (age-related) population. Distribution of scores was wide on all PROMIS item banks. Discussion & conclusion: Outcomes of this young adult cohort are heterogeneous and individualized approaches are therefore needed. Long-term seizure control with pyridoxine was achieved for almost all patients. Neurologic symptoms were noted in the majority, including tremors, as well as neuro-imaging abnormalities and intellectual disability, additionally reflected by the PROMIS Cognitive Functioning. PDE-ALDH7A1 patients scored comparable to the general population on all other PROMs, especially regarding Ability to Participate and Satisfaction with Social Roles this may indicate a positive interpretation of their functioning. The aim is to expand this pilot study to larger populations to obtain more solid data, and to advance the use of PROMs to engage patients in research and provide the opportunity for personalized care.

2.
J Perinatol ; 35(12): 977-81, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26248128

ABSTRACT

To improve the neurologic outcomes for infants with brain injury, neonatal providers are increasingly implementing neurocritical care approaches into clinical practice. Term infants with brain injury have been principal beneficiaries of neurologically-integrated care models to date, as evidenced by the widespread adoption of therapeutic hypothermia protocols for hypoxic-ischemic encephalopathy. Innovative therapeutic and diagnostic support for very low birth weight infants with brain injury has lagged behind. Given that concern for significant future neurodevelopmental impairment can lead to decisions to withdraw life supportive care at any gestational age, providing families with accurate prognostic information is essential for all infants. Current variable application of multidisciplinary neurocritical care approaches to infants at different gestational ages may be ethically problematic and reflect distinct perceptions of brain injury for infants born extremely premature.


Subject(s)
Integrative Medicine/methods , Intensive Care, Neonatal/standards , Neonatology/methods , Neurodevelopmental Disorders/diagnosis , Neurodevelopmental Disorders/therapy , Decision Making , Echoencephalography , Female , Gestational Age , Humans , Hypothermia, Induced/methods , Hypoxia-Ischemia, Brain/therapy , Infant , Infant, Extremely Premature , Infant, Newborn , Infant, Very Low Birth Weight , Magnetic Resonance Imaging , Male , Pregnancy , Treatment Outcome
4.
Neurogenetics ; 6(3): 143-9, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16075246

ABSTRACT

Pyridoxine-dependent seizure (PDS) is a rare autosomal recessive intractable seizure disorder only controlled by a daily supplementation of pharmacological doses of pyridoxine (Vitamin B6). Although glutamate decarboxylase utilizes pyridoxal phosphate as a cofactor during conversion of the excitatory amino acid, glutamate, to the inhibitory neurotransmitter, gamma-amino butyric acid (GABA), several studies have failed to demonstrate a linkage to either of the glutamate-decarboxylase-encoding genes (GAD1 and GAD2) and PDS excluding involvement of this functional candidate. However, in 2000, a locus for PDS was mapped to a 5 cM interval at chromosome 5q31 in four consanguineous and one multisib pedigree (Z(max)=8.43 at theta=0 for marker D5S2017) [Cormier-Daire et al. in Am J Hum Genet 67(4):991-993 2000]. We undertook molecular genetic studies of six nonconsanguineous North American families, using up to ten microsatellite markers to perform haplotype segregation analysis of the 5q31 locus. Assignment to the chromosome 5q PDS locus was excluded in one of the six North American PDS pedigrees, as chromosome 5q31 haplotypes were incompatible with linkage to this locus. The remaining five PDS pedigrees showed haplotype segregation consistent with linkage to 5q31, generating a maximum combined lod score of 1.87 (theta=0) at marker D5S2011. In this study, we establish genetic heterogeneity for PDS, catalog 21 genes within the originally defined PDS interval, and identify additional recombinations that indicate a higher priority interval, containing just 11 genes.


Subject(s)
Chromosome Disorders/genetics , Chromosomes, Human, Pair 5 , Pyridoxine/adverse effects , Seizures/chemically induced , Chromosome Mapping , Female , Genes, Recessive , Genetic Heterogeneity , Genetic Markers , Humans , Male , Pedigree , Seizures/genetics
5.
Arch Dis Child ; 83(5): 439-42, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11040156

ABSTRACT

Progressive myelopathy is a rare complication of chronic hepatic disease which has never been reported in the paediatric age group. We describe the 11 year course of an adolescent male with hepatic myelopathy caused by cryptogenic micronodular cirrhosis. His condition has been associated with persistent polycythaemia and extraordinary increases of whole blood manganese, with magnetic resonance imaging evidence of manganese deposition within the basal ganglia and other regions of the brain. The patient has developed neither liver failure nor parkinsonism. The pathophysiological bases of this multiorgan system disorder are described.


Subject(s)
Liver Cirrhosis/complications , Manganese/blood , Paraparesis, Spastic/etiology , Polycythemia/etiology , Adolescent , Chronic Disease , Follow-Up Studies , Humans , Liver Cirrhosis/blood , Male
6.
Neurology ; 55(2): 309-11, 2000 Jul 25.
Article in English | MEDLINE | ID: mdl-10908915

ABSTRACT

Several aspects of pyridoxine-dependent seizure (PDS) suggest a mutation affecting glutamate decarboxylase (GAD) as a possible cause. To examine the possibility of GAD linkage with PDS, the authors performed genotype analyses of three families using polymorphic markers near the GAD genes (GAD1 and GAD2). In each family, the affected siblings exhibited different genotypes for the GAD2 gene; in two families the GAD1 genotype was disparate. These findings suggest that a mutation of GAD is not directly involved in all cases of PDS.


Subject(s)
Genetic Linkage/genetics , Genotype , Glutamate Decarboxylase/genetics , Pyridoxine/administration & dosage , Spasms, Infantile/genetics , Vitamin B 6 Deficiency/genetics , Alleles , Child , Child, Preschool , DNA Mutational Analysis , Female , Genetic Markers/genetics , Humans , Infant , Infant, Newborn , Isoenzymes/genetics , Male
7.
Pediatr Res ; 47(3): 362-8, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10709736

ABSTRACT

Toluene inhalant abuse during pregnancy may result in growth-retarded microcephalic newborns who subsequently demonstrate developmental impairment. By using a rat model of toluene-abuse embryopathy, we studied the effects of prenatal toluene exposure on the generation and migration of cortical neurons. Dams were exposed by gavage to either corn oil or toluene diluted in corn oil on d 6-21 of gestation. The time of origin of cortical neurons was determined in the mature pups of dams injected with the thymidine analogue 5'-bromodeoxyuridine on 1 d during the period from d 13-21 of gestation. 5'-Bromodeoxyuridine-labeled neurons were identified by immunohistochemistry in a 400-microm-wide column of somatosensory cortex. The brains of the toluene-exposed pups had a significant reduction in the number of neurons within each cortical layer (p < 0.001). Depending on the cortical layer, the generation of neurons in the toluene-exposed pups was delayed by 1 or 2 d. In addition, the brains of the toluene-exposed pups also showed evidence of abnormal neuronal migration. However, there were no differences in either brain weight or body weight between the control and toluene-exposed pups. These observations suggest that although prenatal toluene exposure results in abnormal neuronal proliferation and migration, brain weight in the toluene-exposed pups may be preserved by enhanced development of glia or the neuropil.


Subject(s)
Somatosensory Cortex/drug effects , Teratogens , Toluene/toxicity , Animals , Female , Pregnancy , Rats , Rats, Sprague-Dawley , Somatosensory Cortex/embryology , Somatosensory Cortex/pathology , Toluene/administration & dosage
9.
Neurology ; 51(1): 74-8, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9674782

ABSTRACT

BACKGROUND: Pyridoxine dependency is an uncommon familial cause of intractable seizures in newborns and infants. Fewer than 100 patients have been reported, and only four reports have included examples of brain imaging findings. We report the first longitudinal MRI findings in two patients with this condition. METHODS: Six brain MR scans, three each from two patients with pyridoxine-dependent seizures, were reviewed. Morphometry of selected axial images was performed to calculate the ventricle-to-brain ratio (VBR). PATIENTS: A girl, followed for 5 years, presented with intrauterine fetal seizures and neonatal seizures, and pyridoxine dependency was confirmed at 3.5 months of age. This patient had a subsequent history of poor compliance with pyridoxine therapy and severe developmental disability. A boy, followed for 9 years, presented with neonatal seizures, and pyridoxine dependency was diagnosed at 8 months of age. RESULTS: The serial MR scans demonstrated progressive dilation of the ventricular system and atrophy of the cortex and subcortical white matter together with an increase in the VBR. These progressive abnormalities were greater in the 5-year-old girl. CONCLUSION: Pyridoxine-dependent seizures are due to an inborn abnormality in the pyridoxine-dependent synthesis of gamma-aminobutyric acid (GABA). The progressive MR changes may be due to chronic excitotoxicity caused by an imbalance of cerebral levels of GABA and glutamic acid.


Subject(s)
Epilepsy/diagnosis , Epilepsy/etiology , Glutamate Decarboxylase/deficiency , Magnetic Resonance Imaging , Pyridoxine/administration & dosage , Atrophy , Brain/metabolism , Brain/pathology , Brain/physiopathology , Child , Child, Preschool , Epilepsy/metabolism , Epilepsy/pathology , Female , Humans , Infant , Infant, Newborn , Longitudinal Studies , Male , gamma-Aminobutyric Acid/metabolism
11.
Reprod Toxicol ; 12(2): 119-26, 1998.
Article in English | MEDLINE | ID: mdl-9535505

ABSTRACT

To determine the longitudinal effects of prenatal exposure to toluene in rats, dams received daily gavage doses of toluene diluted in corn oil on Days 6 through 19 of gestation, whereas control dams received corn oil. Litters were evaluated either on Gestational Day 19, Postnatal Day 10, or Postnatal Day 21; morphometric analysis of brain and measurements of brain DNA, cholesterol, and protein were made. Prenatal toluene exposure produced growth retarded fetuses with smaller brain and caudate-putamen volumes, fewer forebrain cell nuclei (DNA), and a reduction in both hindbrain cell size (protein/DNA) and myelination per cell (cholesterol/DNA). Postnatal catch-up growth occurred in the prenatally toluene-exposed pups, and by Postnatal Day 21 these differences had resolved. However, on Postnatal Day 21, a significant reduction in forebrain myelination/cell was present in the prenatally toluene-exposed pups. Therefore, whereas the effects of toluene administered prior to the time of the brain growth spurt were, for the most part, reversible, these exposures resulted in reduced forebrain myelination that may be permanent.


Subject(s)
Brain/drug effects , Embryonic and Fetal Development/drug effects , Prenatal Exposure Delayed Effects , Toluene/toxicity , Administration, Oral , Animals , Body Weight/drug effects , Brain/embryology , Brain/pathology , Brain Chemistry/drug effects , Cell Count/drug effects , Cell Nucleus/drug effects , Female , Litter Size/drug effects , Male , Myelin Sheath/drug effects , Organ Size/drug effects , Pregnancy , Rats , Rats, Sprague-Dawley , Survival Rate
12.
Muscle Nerve ; 20(12): 1595-7, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9390675

ABSTRACT

Guillain-Barré syndrome can very rarely present with acute quadripares and cranial nerve involvement resembling a locked-in state. We describe a very unusual case of fulminant neuropathy in a child who was previously exposed to vincristine. The clinical picture resembled brain death; however, electrodiagnostic studies led to the diagnosis of a peripheral neuropathy. Serial electrodiagnostic studies and pathologic findings confirmed demyelination.


Subject(s)
Brain Death/diagnosis , Polyradiculoneuropathy/diagnosis , Biopsy , Child , Clinical Laboratory Techniques , Diagnosis, Differential , Electrodiagnosis , Humans , Immunoglobulins, Intravenous/therapeutic use , Magnetic Resonance Imaging , Male , Polyradiculoneuropathy/therapy , Sural Nerve/pathology
13.
Pediatrics ; 98(5): 944-7, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8909490

ABSTRACT

BACKGROUND: Hepatic and neurologic injury developed in two infants after ingestion of mint tea. Examination of the mint plants, from which the teas were brewed, indicated that they contained the toxic agent pennyroyal oil. METHODS: Sera from each infant were analyzed for the toxic constituents of pennyroyal oil, including pulegone and its metabolite menthofuran. RESULTS: Fulminant liver failure with cerebral edema and necrosis developed in the first infant, who died. This infant was positive only for menthofuran (10 ng/mL). In the other infant, who was positive for both pulegone (25 ng/mL) and menthofuran (41 ng/mL), hepatic dysfunction and a severe epileptic encephalopathy developed. CONCLUSION: Pennyroyal oil is a highly toxic agent that may cause both hepatic and neurologic injury if ingested. A potential source of pennyroyal oil is certain mint teas mistakenly used as home remedies to treat minor ailments and colic in infants. Physicians should consider pennyroyal oil poisoning as a possible cause of hepatic and neurologic injury in infants, particularly if the infants may have been given home-brewed mint teas.


Subject(s)
Beverages/poisoning , Cyclohexanones/poisoning , Monoterpenes , Multiple Organ Failure/chemically induced , Oils, Volatile/poisoning , Brain Diseases/chemically induced , Brain Edema/chemically induced , Cyclohexane Monoterpenes , Epilepsy/chemically induced , Humans , Infant , Liver Failure, Acute/chemically induced , Male , Menthol/analogs & derivatives , Menthol/poisoning , Necrosis , Terpenes/poisoning
14.
Pediatr Res ; 40(1): 82-7, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8798251

ABSTRACT

A rat model was developed to study toluene-abuse embryopathy, a clinical syndrome which occurs in offspring of women who abuse toluene during pregnancy. On d 6-19 of gestation, eight dams received a daily gavage dose of toluene, 650 mg/kg body weight, diluted in corn oil, whereas eight control dams and eight pair-fed dams received corn oil. The fetuses were delivered on d 19 of gestation. In the toluene-exposed group, the weights of the fetuses were reduced by 21.6% (p < 0.001), and a delay in skeletal ossification was demonstrated. Toluene exposure significantly reduced the weight of the fetal brain by 11.9% (p < 0.001), as well as the weights of the heart, liver, and kidney. Organ weight/body weight ratios did not differ significantly. Morphometric analysis of brain sections demonstrated that toluene exposure resulted in smaller brains together with an increase in the size of the ventricular system and a reduction in the size of the caudate nucleus. Although toluene exposure resulted in a 13.7% reduction in maternal food consumption, the observations made in the pair-fed group did not differ from those made in the control group. These findings suggest that prenatal exposure to toluene results in generalized fetal growth retardation, and that these effects are not due to the reduction in maternal food consumption.


Subject(s)
Abnormalities, Drug-Induced/etiology , Substance-Related Disorders , Toluene , Analysis of Variance , Animals , Brain/drug effects , Disease Models, Animal , Eating/drug effects , Female , Organ Size/drug effects , Ossification, Heterotopic/chemically induced , Pregnancy , Rats , Rats, Sprague-Dawley , Weight Gain/drug effects
15.
Dev Med Child Neurol ; 38(6): 549-53, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8647335

ABSTRACT

An 8-month-old boy presented with a two-day history of lethargy. Meningitis was suspected, and cerebrospinal fluid examination demonstrated pleocytosis and elevated protein. After initial improvement with antibiotic and steroid therapy, progressive lower extremity weakness developed, and a midthoracic spinal cord arteriovenous malformation (AVM) was diagnosed. These lesions present rarely in infancy; the classification and pathophysiology of spinal cord AVMs are reviewed.


Subject(s)
Arteriovenous Malformations/diagnosis , Meningitis, Aseptic/etiology , Spinal Cord/blood supply , Arteriovenous Malformations/complications , Diagnosis, Differential , Humans , Infant , Male , Meningitis, Bacterial/diagnosis
16.
Pediatr Res ; 39(3): 494-8, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8929871

ABSTRACT

We evaluated whether environmental tobacco smoke exposure in utero and/or postnatally affects the biochemical composition of the brain. Pregnant Sprague-Dawley rats were exposed to filtered air (FA) or to sidestream smoke (SS) for 4 h/d, 7 d/wk from d 3 of pregnancy until delivery, then their female pups were exposed to either FA or SS for 9 wk postnatally. This resulted in four exposure conditions: in utero FA followed by postnatal FA (FA/FA), in utero FA followed by postnatal SS (FA/SS), in utero SS followed by postnatal FA (SS/FA), and in utero SS followed by postnatal SS (SS/SS). After completion of the exposures, the brains were removed and divided at the pontomesencephalic junction into forebrain and hindbrain; each specimen was then analyzed for DNA, protein, and cholesterol concentration. Data were analyzed by 2-way analysis of variance. In utero SS had no effect on these three biochemical measurements. However, postnatal SS reduced hindbrain DNA concentration (an indicator of cellular density) by 4.4% (p = 0.001). In addition, the hindbrain protein/DNA ratio (an index of cell size) was increased in these animals by 8.4% (p = 0.001). Hindbrain weight was not affected by SS exposure, but body weight was reduced by 6.4% (p = 0.016). These data suggest that postnatal exposure to SS affects the hindbrain (a region which undergoes significant postnatal growth) by reducing the total number of cells and by increasing cell size. Hindbrain cellular hypertrophy may help offset the decrease in cell number, thereby leaving hindbrain weight unchanged. Despite preserved hindbrain weight, these effects of postnatal exposure to SS may result in neurologic dysfunction.


Subject(s)
Brain/metabolism , DNA/metabolism , Environmental Exposure/adverse effects , Proteins/metabolism , Smoking/adverse effects , Animals , Brain/growth & development , Female , Pregnancy , Rats , Rats, Sprague-Dawley
17.
Physiol Behav ; 58(5): 935-41, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8577891

ABSTRACT

Weanling mice were fed an amino acid-based diet supplemented with 0 or 11.3 mumol folic acid/kg diet for approximately 38 days to study behavior and neurochemistry in folate deficiency. After approximately 5 wk, mice fed the unsupplemented diet weighted approximately 70% as much those fed the supplemented diet. After 2 wk, mice fed the unsupplemented diet consistently discarded (spilled) more food, and after approximately 5 wk, they had spilled 3 times more than mice fed the supplemented diet. Serum folate, brain folate and brain S-adenosylmethionine of mice fed the unsupplemented diet were 4, 53, and 60% as high, respectively, as those of mice fed the supplemented diet. Pathologic changes were not evident in brain, spinal cord, or skeletal muscle of folate-deficient mice. The hypothalamic 5-hydroxyindole acetic acid/serotonin ratio and caudate dopamine, homovanillic acid, and 3,4-dihydroxyphenylacetic acid concentrations were lower in deficient than control mice. Folate-deficient mice develop a behavioral activity, food spilling, which may have a neurochemical basis in the serotonin and dopamine systems.


Subject(s)
Behavior, Animal/physiology , Brain Chemistry/physiology , Folic Acid Deficiency/metabolism , Folic Acid Deficiency/psychology , Animals , Behavior, Animal/drug effects , Biogenic Monoamines/metabolism , Blood Cell Count , Body Weight/physiology , Brain/pathology , Caudate Nucleus/metabolism , Feeding Behavior/physiology , Female , Folic Acid Deficiency/pathology , Hypothalamus/metabolism , Mice , Muscle, Skeletal/pathology , S-Adenosylhomocysteine/metabolism , S-Adenosylmethionine/metabolism , Spinal Cord/pathology
18.
Ann Emerg Med ; 26(3): 380-2, 1995 Sep.
Article in English | MEDLINE | ID: mdl-7661433

ABSTRACT

An 11-month-old boy was brought to the pediatric emergency department for evaluation of acute onset of irritability and involuntary side-to-side turning of the head. Neurologic examination revealed cortical blindness. Toxicologic studies of blood and urine were positive for methamphetamine. The infant's vision and activity returned to normal within 12 hours. The possible mechanisms of this unusual form of amphetamine toxicity are discussed.


Subject(s)
Blindness/chemically induced , Methamphetamine/poisoning , Acute Disease , Akathisia, Drug-Induced/etiology , Blindness/diagnosis , Cerebral Cortex/drug effects , Diagnosis, Differential , Dyskinesia, Drug-Induced/etiology , Humans , Infant , Male , Methamphetamine/blood , Methamphetamine/urine , Neurologic Examination
19.
Neurology ; 45(8): 1526-32, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7644053

ABSTRACT

The spatial distribution of metabolite signal intensities can be measured within entire sections of the brain by proton magnetic resonance spectroscopic imaging (1H-MRSI). A group of six patients (4 unrelated girls and 2 brothers from 5 families) with childhood ataxia with diffuse CNS hypomyelination (CACH) underwent long-echo-time, single-slice 1H-MRSI. Relative to controls, there was a decrease in the signal intensity of N-acetylaspartate, choline, and creatine throughout the white matter in all six patients. We identified lactate signals in white matter in three of them with advanced disease. The degree of white matter involvement was not homogeneous over the entire patient group, but did correlate with clinical presentation. Deep and posterior white matter tended to be more involved. There were no 1H-MRSI abnormalities in the gray matter. 1H-MRSI findings suggest that this syndrome is secondary to a metabolic defect causing hypomyelination, axonal degeneration, and, in the most compromised cases, accumulation of lactate. This study shows that CACH is not limited to girls.


Subject(s)
Ataxia/diagnosis , Brain Diseases/diagnosis , Brain Diseases/pathology , Magnetic Resonance Spectroscopy , Myelin Sheath/pathology , Aspartic Acid/analogs & derivatives , Aspartic Acid/metabolism , Brain/metabolism , Child, Preschool , Choline/metabolism , Creatine/metabolism , Female , Gaucher Disease/diagnosis , Humans , Lactates/metabolism , Lactic Acid , Magnetic Resonance Imaging , Male , Protons
20.
Stroke ; 26(4): 699-701, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7709420

ABSTRACT

BACKGROUND: Infantile polyarteritis nodosa usually presents in children under 2 years of age as a multiorgan system disease with signs of congestive heart failure or renal failure. This disease and Kawasaki disease may share certain clinical and pathological features. CASE DESCRIPTION: We describe a child who first presented at 8 months of age with a febrile illness followed by a delay in motor and language development and a mild right hemiparesis. Five years later he died after developing oculomotor dysfunction, hypertension, and intracranial hemorrhage. Autopsy revealed focal segmental necrotizing vasculitis of cerebral arteries, without involvement of coronary or renal vessels. CONCLUSIONS: Although this child was evaluated on several occasions during this time period, the diagnosis was not made antemortem. The predominant central nervous system features, both clinical and pathological, together with the prolonged course are the two unique features of this child's disease that need to be emphasized.


Subject(s)
Brain/pathology , Polyarteritis Nodosa/pathology , Brain/blood supply , Brain/diagnostic imaging , Cerebral Angiography , Child, Preschool , Humans , Infant , Polyarteritis Nodosa/diagnostic imaging , Polyarteritis Nodosa/mortality , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...